Human Genome Epidemiology Literature Finder
Records 1 - 2 (of 2 Records) |
Query Trace: Weight Loss and KRAS[original query] |
---|
Chemoradiotherapy and gefitinib in stage III non-small cell lung cancer with epidermal growth factor receptor and KRAS mutation analysis: cancer and leukemia group B (CALEB) 30106, a CALGB-stratified phase II trial. Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer 2010 Sep 5 (9): 1382-90. Ready Neal, Jänne Pasi A, Bogart Jeffrey, Dipetrillo Thomas, Garst Jennifer, Graziano Stephen, Gu Lin, Wang Xiaofei, Green Mark R, Vokes Everett E, |
The Prognostic Influence of BRAF Mutation and other Molecular, Clinical and Laboratory Parameters in Stage IV Colorectal Cancer. Pathology oncology research : POR 2016 Mar . Karadima Maria L, Saetta Angelica A, Chatziandreou Ilenia, Lazaris Andreas C, Patsouris Efstratios, Tsavaris Nikola |
- Page last reviewed:Feb 1, 2024
- Page last updated:Apr 29, 2024
- Content source: